Contact
Please use this form to send email to PR contact of this press release:
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents
TO:
Please use this form to send email to PR contact of this press release:
Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents
TO: